Abstract:Abstract Background The discovery of the importance of angiogenesis in tumor growth has emphasized the need to find specific vascular targets for tumor-targeted therapies. Previously, using phage display technology, we identified the peptide GX1 as having the ability to target the gastric cancer vasculature. The present study investigated the bioactivities of GX1, as well as its potential ability to cooperate with recombinant mutant human tumor necrosis factor alpha (rmhTNFα), in gastric cancer therapy. Results Tetrazolium salt (MTT) assay showed that GX1 could inhibit cell proliferation of both human umbilical vein endothelial cells (HUVEC) (44%) and HUVEC with tumor endothelium characteristics, generated by culturing in tumor-conditioned medium (co-HUVEC) (62%). Flow-cytometry (FCM) and western blot assays showed that GX1 increased the rate of apoptosis from 11% to 31% (p < 0.01) by up-regulating caspase 3 expression level. A chorioallantoic membrane assay indicated that GX1 could suppress neovascularization in vivo, with the microvessel count decreasing from 21 to 11 (p < 0.05). When GX1 was fused to rmhTNFα, GX1-rmhTNFα selectively concentrated in the gastric cancer vasculature, as shown by enzyme-linked immunosorbent assay, immunofluorescence and emission-computed tomography. In vitro MTT and FCM assays showed that, compared to rmhTNFα alone, GX1-rmhTNFα was more effective at suppressing co-HUVEC proliferation (45% vs. 61%, p < 0.05) and inducing apoptosis (11% vs. 23%, p < 0.05). In a tumor formation test, GX1-rmhTNFα more effectively inhibited tumor growth than rmhTNFα (tumor volume: 271 mm3 vs. 134 mm3, p < 0.05), with less systemic toxicity as measured by body weight (20.57 g vs. 19.30 g, p < 0.05). These therapeutic effects may be mediated by selectively enhanced tumor vascular permeability, as indicated by Evan's blue assay. Conclusion GX1 had both homing activity and the ability to inhibit vascular endothelial cell proliferation in vitro and neovascularization in vivo. Furthermore, when GX1 was conjugated to rmhTNFα, the fusion protein was selectively delivered to targeted tumor sites, significantly improving the anti-tumor activity of rmhTNFα and decreasing systemic toxicity. These results demonstrate the potential of GX1 as a homing peptide in vascular targeted therapy for gastric cancer.

The CNGRCLLII(KLAKLAK)2 Peptide Shows Cytotoxicity Against HUVECs by Inducing Apoptosis: an in Vitro and in Vivo Study

Antitumor Activity of Antimicrobial Peptides Containing CisoDGRC in CD13 Negative Breast Cancer Cells

Inhibiting Effects of a Cyclic Peptide CNGRC on Proliferation and Migration of Tumor Cells In Vitro

Modification Of Cyclic Ngr Tumor Neovasculature-Homing Motif Sequence To Human Plasminogen Kringle 5 Improves Inhibition Of Tumor Growth

A Novel Peptide From Human Apolipoprotein(A) Inhibits Angiogenesis And Tumor Growth By Targeting C-Src Phosphorylation In Vegf-Induced Human Umbilical Endothelial Cells

Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization

A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities

Lentivirus Vector-Mediated Gene Transduction of Cngrc Peptide in Rat Adipose Stem Cells

An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13− tumor cells

A Novel Antiangiogenic Peptide Derived From Hepatocyte Growth Factor Inhibits Neovascularization In Vitro And In Vivo

A Novel Peptide Specifically Binding to VEGF Receptor Suppresses Angiogenesis in Vitro and in Vivo

Therapeutic Targeting of Angiogenesis with a Recombinant CTT Peptide–Endostatin Mimic–Kringle 5 Protein

Screening of Functionalized Self-Assembling Peptide Nanofiber Scaffolds with Angiogenic Activity for Endothelial Cell Growth

Smart pH-Sensitive Nanogels for Enhancing Synergistic Anticancer Effects of Integrin αvβ3 Specific Apoptotic Peptide and Therapeutic Nitric Oxide

A Novel Peptide (GX1) Homing to Gastric Cancer Vasculature Inhibits Angiogenesis and Cooperates with TNF Alpha in Anti-Tumor Therapy

Inhibitory Effects of Novel Integrin-Targeting Peptides on Angiogenesis Activity in HUVEC Cells in Vitro.

Fluorescent RGD-based Pro-Apoptotic Peptide Conjugates As Mitochondria-Targeting Probes for Enhanced Anticancer Activities.

Screening and construction of nanobodies against human CD93 using phage libraries and study of their antiangiogenic effects

In Vivo Studies on Angiogenic Activity of Two Designer Self-Assembling Peptide Scaffold Hydrogels in the Chicken Embryo Chorioallantoic Membrane

Specific Targeting of the Vasculature of Gastric Cancer by a New Tumor-Homing Peptide CGNSNPKSC.

A VEGFR Targeting Peptide-Drug Conjugate (PDC) Suppresses Tumor Angiogenesis in a TACE Model for Hepatocellular Carcinoma Therapy